Live Science – by Laura Geggel
Popular genetics-testing company 23andMe is partnering with drug giant GlaxoSmithKline to use people’s DNA to develop medical treatments, the company announced in a blog post yesterday (July 25).
During the four-year collaboration, the London-based GlaxoSmithKline will use 23andMe’s genetic database to zero in on possible targets and treatments for human disease. Continue reading “23andMe Is Sharing Its 5 Million Clients’ Genetic Data with Drug Giant GlaxoSmithKline”
